OpenFilings
Oruka Therapeutics, Inc.
Form
8-K
Report Period
2026-05-29
Date Filed
2026-06-01
Time Filed
16:01:27
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
FIRST AMENDMENT TO IL-23 LICENSE AGREEMENT, DATED MAY 29, 2026
Filing on SEC Edgar